Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NKX3-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
STARD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOPC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TLR8-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00161 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIRPA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNA1H - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MKRN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC187 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRTAP19-1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRAC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KHDRBS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSD11B1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on